Evidence map›Paper›PMID 38651880›Full record

ArticleMicrobiology spectrum2024

International circumpolar surveillance: update on the interlaboratory quality control program for

Alyssa R Golden, Averil Griffith, Brenna C Simons, Alisa Reasonover, Hans-Christian Slotved, Brigitte Lefebvre, Karl G Kristinsson, Donna Hurteau, Gregory J Tyrrell, Michael G Bruce and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Alyssa R GoldenNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.ORCID 0000-0002-1788-1794
Averil GriffithNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Brenna C SimonsArctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Alisa ReasonoverArctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Hans-Christian SlotvedNeisseria and Streptococcus Reference Laboratory, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Brigitte LefebvreLaboratoire de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
Karl G KristinssonDepartment of Clinical Microbiology, Landspitali - the National University Hospital of Iceland, Reykjavik, Iceland.
Donna HurteauAlberta Precision Laboratory - Public Health Laboratory and Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
Gregory J TyrrellAlberta Precision Laboratory - Public Health Laboratory and Division of Diagnostic and Applied Microbiology, Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
Michael G BruceArctic Investigations Program, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Irene MartinNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.ORCID 0000-0002-3941-5583
Centers for Disease Control and Prevention · USPublic Health Agency of Canada · CAUniversity of Alberta · CANational University Hospital of Iceland · ISStatens Serum Institut · DKSte. Anne's Hospital · CA

Funding

Public Health Agency of Canada (PHAC) Internal funding
6 · The paper itself

Abstract

The International Circumpolar Surveillance (ICS) program is a population-based surveillance network for invasive bacterial diseases throughout Arctic countries and territories. The ICS quality control program for IMPORTANCE: Arctic populations experience several social and physical challenges that lead to the increased spread and incidence of invasive diseases. The International Circumpolar Surveillance (ICS) program was developed to monitor five invasive bacterial diseases in Arctic countries and territories. Each ICS organism has a corresponding interlaboratory quality control (QC) program for laboratory-based typing, to ensure the technical precision and accuracy of reference testing services for these regions, and identify and correct potential problems. Here, we describe the results of the ICS

Indexed as

Anti-Bacterial AgentsMicrobial Sensitivity TestsPneumococcal InfectionsQuality ControlStreptococcus pneumoniaeAlaskaArctic RegionsEpidemiological MonitoringHumansLaboratoriesSerogroupSerotypingAnti-Bacterial Agentsantimicrobial susceptibilitycircumpolar surveillanceinvasive bacterial diseasequality controlserotypingStreptococcus pneumoniae

Identifiers

PMID38651880
PMCPMC11237448
OpenAlexW4395037761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.